195 related articles for article (PubMed ID: 27215763)
1. The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction.
Eyal N
J Med Ethics; 2017 Feb; 43(2):65-66. PubMed ID: 27215763
[TBL] [Abstract][Full Text] [Related]
2. For love and money: the need to rethink benefits in HIV cure studies.
Largent E
J Med Ethics; 2017 Feb; 43(2):96-99. PubMed ID: 27193021
[TBL] [Abstract][Full Text] [Related]
3. Afterword: returning to philosophical foundations in research ethics.
Eyal N
J Med Ethics; 2017 Feb; 43(2):132-133. PubMed ID: 27354247
[TBL] [Abstract][Full Text] [Related]
4. How to keep high-risk studies ethical: classifying candidate solutions.
Eyal N
J Med Ethics; 2017 Feb; 43(2):74-77. PubMed ID: 27288098
[TBL] [Abstract][Full Text] [Related]
5. Informed consent to HIV cure research.
Bromwich D; Millum JR
J Med Ethics; 2017 Feb; 43(2):108-113. PubMed ID: 27288096
[TBL] [Abstract][Full Text] [Related]
6. An activist's argument that participant values should guide risk-benefit ratio calculations in HIV cure research.
Evans D
J Med Ethics; 2017 Feb; 43(2):100-103. PubMed ID: 28062651
[TBL] [Abstract][Full Text] [Related]
7. First-in-human HIV-remission studies: reducing and justifying risk.
Dresser R
J Med Ethics; 2017 Feb; 43(2):78-81. PubMed ID: 27143494
[TBL] [Abstract][Full Text] [Related]
8. The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa.
Moodley K; Staunton C; Rossouw T; de Roubaix M; Duby Z; Skinner D
BMC Med Ethics; 2019 Jan; 20(1):9. PubMed ID: 30678664
[TBL] [Abstract][Full Text] [Related]
9. Must research benefit human subjects if it is to be permissible?
Wikler D
J Med Ethics; 2017 Feb; 43(2):114-117. PubMed ID: 27573151
[TBL] [Abstract][Full Text] [Related]
10. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.
Moodley K; Staunton C; de Roubaix M; Cotton M
AIDS Care; 2016; 28(4):524-7. PubMed ID: 26565595
[TBL] [Abstract][Full Text] [Related]
11. Why cure, why now?
Kuritzkes DR
J Med Ethics; 2017 Feb; 43(2):67-70. PubMed ID: 27273887
[TBL] [Abstract][Full Text] [Related]
12. Informed consent for HIV cure research in South Africa: issues to consider.
Staunton C
BMC Med Ethics; 2015 Jan; 16():3. PubMed ID: 25591806
[TBL] [Abstract][Full Text] [Related]
13. Cure research and consent: the Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney.
Annas GJ
J Med Ethics; 2017 Feb; 43(2):104-107. PubMed ID: 27165841
[TBL] [Abstract][Full Text] [Related]
14. The social value of candidate HIV cures: actualism versus possibilism.
Brown R; Evans NG
J Med Ethics; 2017 Feb; 43(2):118-123. PubMed ID: 27402887
[TBL] [Abstract][Full Text] [Related]
15. Microbicide research in developing countries: have we given the ethical concerns due consideration?
Moodley K
BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
[TBL] [Abstract][Full Text] [Related]
16. Does informed consent to research require comprehension?
Sreenivasan G
Lancet; 2003 Dec; 362(9400):2016-8. PubMed ID: 14683665
[No Abstract] [Full Text] [Related]
17. HIV vaccine trials: critical issues in informed consent.
Lindegger G; Richter LM
S Afr J Sci; 2000 Jun; 96():313-7. PubMed ID: 15739286
[TBL] [Abstract][Full Text] [Related]
18. Using Cognitive Interviews to Enhance Measurement in Empirical Bioethics: Developing a Measure of the Preventive Misconception in Biomedical HIV Prevention Trials.
Sugarman J; Seils DM; Watson-Ormond JK; Weinfurt KP
AJOB Empir Bioeth; 2016; 7(1):17-23. PubMed ID: 27747258
[TBL] [Abstract][Full Text] [Related]
19. Current ethical issues in HIV/AIDS research and HIV/AIDS care.
Hlongwa P
Oral Dis; 2016 Apr; 22 Suppl 1():61-5. PubMed ID: 27109274
[TBL] [Abstract][Full Text] [Related]
20. The fair transaction model of informed consent: an alternative to autonomous authorization.
Miller FG; Wertheimer A
Kennedy Inst Ethics J; 2011 Sep; 21(3):201-18. PubMed ID: 22073815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
